Form 4: Ulta Beauty CFO Receives Stock Grant and Options
Insider Transaction Report
Ulta Beauty's Chief Financial Officer, Christopher DelOrefice, was granted restricted stock and stock options as part of his compensation.
Summary
- Christopher DelOrefice, Chief Financial Officer of Ulta Beauty, Inc., reported transactions involving securities on March 31, 2026.
- He received a grant of 4,219 shares of restricted stock, which will fully vest on March 15, 2029.
- Additionally, DelOrefice was granted stock options to purchase 14,363 shares of common stock.
- These options vest in 25% increments annually, starting March 15, 2027, and continuing through March 15, 2030.
- Following these transactions, DelOrefice beneficially owns 9,693 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports standard executive compensation practices rather than financial performance or strategic shifts.
Positives
- The CFO received a significant grant of restricted stock and stock options, indicating continued investment in key management personnel.
- The stock options provide a long-term incentive tied to the company's performance, with vesting spread over several years.
Negatives
- No negative financial results or operational issues are disclosed in this filing.
Risks
- The value of the stock options is subject to market fluctuations and the company's future stock price performance.
- Vesting schedules for stock options and restricted stock could be impacted by unforeseen company performance issues or changes in employment status.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports on the grant of equity awards to the CFO.
Industry Context
StockSavvy.ai notes that the granting of restricted stock and stock options to a Chief Financial Officer is a common practice in the retail beauty industry to attract, retain, and incentivize executive talent, aligning their interests with shareholders.
Stakeholder Impact
- Shareholders: The grants align management's interests with long-term shareholder value creation through equity incentives.
- Employees: This filing does not directly impact employees but reflects standard executive compensation practices within the company.
- Management: The CFO receives compensation tied to company performance and retention.
Next Steps
- Christopher DelOrefice will receive his restricted stock grant on March 15, 2029.
- Stock options will vest in annual installments from March 15, 2027, through March 15, 2030.
Key Dates
| Date | Description |
|---|---|
| 03/15/2027 | First 25% annual vesting increment for stock options begins. |
| 03/15/2029 | Full vesting date for the restricted stock grant. |
| 03/15/2030 | Final 25% annual vesting increment for stock options. |
| 03/31/2026 | Transaction date for the grant of restricted stock and stock options. |
| 04/02/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Ulta Beauty, ULTA, Form 4, Stock Options, Restricted Stock, Insider Trading, Executive Compensation, CFO, Christopher DelOrefice
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.